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Abstract
Neuroscience is a technology-driven discipline and brain energy metabolism is no exception. Once 
satisfied with mapping metabolic pathways at organ level, we are now looking to learn what it is 
exactly that metabolic enzymes and transporters do and when, where do they reside, how are they 
regulated, and how do they relate to the specific functions of neurons, glial cells, and their 
subcellular domains and organelles, in different areas of the brain. Moreover, we aim to quantify 
the fluxes of metabolites within and between cells. Energy metabolism is not just a necessity for 
proper cell function and viability but plays specific roles in higher brain functions such as memory 
processing and behavior, whose mechanisms need to be understood at all hierarchical levels, from 
isolated proteins to whole subjects, in both health and disease. To this aim the field takes 
advantage of diverse disciplines including anatomy, histology, physiology, biochemistry, 
bioenergetics, cellular biology, molecular biology, developmental biology, neurology and 
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mathematical modeling. This article presents a well-referenced synopsis of the technical side of 
brain energy metabolism research. Detail and jargon are avoided whenever possible and emphasis 
is given to comparative strengths, limitations and weaknesses, information that is often not 
available in regular papers.
Keywords
Organization level; spatio-temporal resolution; in vitro; in vivo
“Each portion of matter may be conceived as like a garden full of plants and like a 
pond full of fishes. But each branch of every plant, each member of every animal, 
each drop of its liquid parts is also some such garden or pond.”
Gottfried W. Leibniz, Monadology 66–69, 1714
Introduction
Picture a student tantalized by one of our favorite questions: How is energy production 
coupled to energy demand? What are the roles of neurons and glial cells in this coupling? 
Information processing controls energy metabolism, but can it also work the other way 
round? Is epilepsy a metabolic disease? Is energy handling at the core of neurodegeneration? 
In search for guidance, she participates in the biennial International Conference on Brain 
Energy Metabolism (http://cecs.cl/icbem/). After listening to talks and reading posters she 
realizes that many different techniques are being applied to many experimental models. Each 
expert uses a different jargon: reversal potential, state 3 respiration, transacceleration, 
cataplerosis, glutamate enrichment, hyperpolarized, pixel shift, BOLD, default network, etc. 
One speaker shows single ion-channel recordings. The next one pyruvate carboxylation by 
mitochondria, and yet another links autofluorescence of mouse hippocampal slices to a 
genetic disease in humans. She leaves the meeting fascinated and bewildered. Would the 
channel behave similarly in situ? Is mitochondrial metabolism sensitive to cytoplasmic 
context? How does invertebrate metabolism relate to human metabolism?
Our purpose here is to offer some technological guidance to our prospective colleagues (and 
to ourselves). Length restrictions preclude covering the ever-expanding technical range, so 
we apologize for possible omissions. Techniques are described and their strengths are stated 
briefly. Special attention is allocated to limitations, problems, and ever elusive underlying 
assumptions. We are not focusing here on the merits of experimental models, which are 
discussed in the article that introduces this special issue. Before going to the specifics, a 
theoretical framework may help to explain why such diverse approaches are required and 
why none of them may claim preference over the others.
Energy metabolism is organized hierarchically
Energy enters the brain as glucose, and leaves it minutes later in the degraded forms of 
water, CO2 and heat. The incessant cascade of electrons is somehow harnessed to maintain 
the complex structure of the brain and to process information. The science of Brain Energy 
Metabolism aims to figure out how this is done. It is a relatively young branch of science, 
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stemming from well-established crafts that bring their own concepts, experimental models 
and techniques, assumptions and flaws: anatomy, histology, physiology, biochemistry, 
bioenergetics, cellular biology, molecular biology, development, neurology, mathematical 
modeling, etc. This pleiotropy is necessary because energy metabolism spans multiple 
organizational levels, from nanometer-scale interactions between intermediate metabolites 
and enzymes to organ-wide modulation of metabolism by hormones and behavior (Fig. 1). 
The existence of structural levels and discernible modules within levels is understood by 
thermodynamics as the expected result of binding forces becoming weaker as small 
structures accrete into larger ones but also has an evolutionary explanation, as building in 
modular fashion dramatically reduces error (Simon, 1962). The hierarchical organization of 
living structures such as the brain makes them amenable to dissection into smaller parts that 
remain functional. Much fundamental knowledge has been acquired from the study of 
isolated brain mitochondria, but which features are context-independent and which are not? 
To what extent does behavior in culture or in slices represent that observed in vivo? A given 
transporter was described and characterized in muscle cells, does it work the same way in 
astrocytes? To what extent is it safe to extrapolate from mouse to human? There are no a 
priori answers to these key questions but a rule of thumb may be applied: the shorter the 
range of the phenomenon, the more likely it is to be unaffected by context. For example the 
18 atoms of glutamate are joined by covalent bonds that withstand 198 °C. Because covalent 
bonds are much stronger than the forces that keep organelles, cells and tissues together, we 
know for sure that the glutamate powder on the shelf is structurally and functionally 
identical to the glutamate released in your visual cortex as you read these words. Thus, 
applying shelf glutamate to cells in culture is meaningful. Likewise, the ligand specificity of 
enzymes, transporters and channels is a robust property that may be characterized in a 
reduced context, i.e. in vitro. However, their regulation is most likely not.
Pick your level, pick your technique
The ideal technique would cover the whole organizational range, offering precise control of 
experimental variables while providing physiologically relevant data that may be reproduced 
by other laboratories. It should also be affordable and accessible. Of course, there is hardly 
such technique and trade-offs become necessary. The illustration in Figure 2 shows how 
some popular approaches distribute over the organizational space. The structure of purified 
enzymes and transporters is studied by means of X-ray diffraction, while understanding their 
function may demand complex systems like vesicles. Oxidative phosphorylation is studied 
by respirometry of isolated mitochondria, where substrates and cofactors are manipulated at 
will and fast phenomena are followed in real-time, or by respirometry of cell populations, 
where experimental control and temporal resolution are sacrificed for the benefit of 
subcellular context and physiological relevance. Cellular and organ level experiments could 
involve imaging of metabolites concentrations in brain cells in vitro and in vivo or optical 
control of signaling in cells of known phenotype. At the end of the spectrum are minimally 
invasive techniques like magnetic resonance spectroscopy (MRS), positron-emission 
tomography (PET) scanning and functional magnetic resonance imaging (fMRI), the only 
methods that may be used in human subjects.
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A The stage: expression, location and interactions of enzymes and transporters
Energy metabolism is distributed across the diverse cellular and subcellular compartments of 
brain tissue. Division of labor among compartments is evident from clear segregation of key 
enzyme activities, for example the almost exclusive astrocytic expression of glutamine 
synthase and pyruvate carboxylase (Martinez-Hernandez et al., 1977; Schousboe et al., 
1977; Yu et al., 1983), which inform on the preferential role of these cells in glutamate 
recycling and anaplerosis. Differences between compartments have also emerged from the 
study of RNA transcripts in identified cell types acutely isolated from brain tissue by FACS 
(Cahoy et al., 2008; Zhang et al., 2014). Recently, the possible introduction of expression 
artifacts by the sorting procedure was minimized by the ingenious expedient of co-culturing 
neurons and glial cells from different species followed by RNA sequencing and in-silico 
separation of the transcripts (Hasel et al., 2017).
A.1 How to approach structure based on microscopy—Microscopy has been the 
technique of choice for investigating the subcellular localization of the various enzymes, 
transporters and other proteins involved in brain metabolism. In order to make these targets 
visible under the microscope, different labeling techniques have been used. One group is 
based on the conversion by the target protein of a chemical substance that becomes a dye 
accumulating locally within the cell and that can be visualized by bright field microscopy 
(e.g. DAB staining of cytochrome oxidase (Hevner and Wong-Riley, 1989; Wong-Riley, 
1989). The other major group makes use of antibodies that can specifically recognize the 
protein of interest (Martinez-Hernandez et al., 1977; Vannucci et al., 1997; Choeiri et al., 
2002; Lehre et al., 1995; Chaudhry et al., 1995; Pierre et al., 2002; Bergersen et al., 2005; 
Pierre et al., 2009). After applying a primary antibody specific for the target protein, a 
secondary antibody directed against the primary antibody and carrying a tag is used to 
visualize its localization. The nature of the tag can vary and will determine the type of 
microscopy that will be subsequently used to reveal the presence of the target protein. The 
tag can be an enzyme which, in the presence of the appropriate substrate, will convert it into 
a dye that accumulates locally and can be visualized with bright field microscopy (e.g. 
peroxidase/DAB). If the tag is fluorescent (e.g. FITC or Cy3), then either widefield 
epifluorescence microscopy may be used, which is more suitable for analysis of tissue 
cultures and larger overviews, or single- and two-photon laser scanning microscopy, which 
can provide a 3D diffraction-limited view of tissues. If the tag is a heavy metal atom (silver 
or gold), then we can use electron microscopy, which increases the spatial resolution power 
compared to conventional brightfield or fluorescence microscopy. The fluorescent peptide or 
protein can then be visualized by fluorescence microscopy (Fig. 3A). Most reagents and 
antibodies are commercially available or can be obtained from the researcher who produced 
them. Two limitation of antibody detection, particularly for comparison purposes, are 
variable affinity and epitope-masking. As an alternative, the mRNA expression of a gene in a 
given cell type may be evaluated with genetic tools. The idea is to modify the gene of 
interest and place the sequence coding for a bright fluorescent protein of a particular color 
(e.g. eGFP, Venus, tdTomato) as a reporter to be expressed under the control of the promoter 
of the target protein. One example of this type of approach is the expression of tdTomato 
under the control of the promoter of the lactate transporter MCT1 gene introduced as 
bacterial artificial chromosome, which revealed preferential MCT1 expression in 
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oligodendrocytes, a finding with consequences for glial-to-neuron lactate shuttling and the 
pathophysiology of white matter neurodegeneration (Lee et al., 2012).
The main strengths of these various techniques and approaches are their capacity to 
distinguish the specific cell type within which a particular protein is found and then in which 
cellular compartment or subcellular domain the protein is localized. From this information, 
which may be obtained under normal, untreated conditions but also after stimulation or 
treatment, it is possible to glen information about the participation of a protein in a particular 
process. In the case of immunofluorescence combined with confocal microscopy, it is 
possible to determine whether two proteins colocalize, i.e. if they are located close to each 
other in the same subcellular compartment. The main limitations of these approaches are the 
specificity and availability of the visualizing reagents. It is essential to demonstrate the 
specificity of each antibody and sometimes good antibodies are unavailable. Resolution can 
also be an issue, depending of the degree of localization that is required. For the genetic 
techniques, discrepancies have been observed between the expression of the native protein 
and the reporter. Care should be taken to avoid over-expression of reporter proteins as this 
could cause abnormal expression patterns or toxic effects. Although ideal for structural/
localization purposes, these methods are rather limited for the study of dynamic processes.
A.2 Protein-protein interactions, supramolecular complexes, and structural 
microdomains—Fick’s law of diffusion states that the time required for a molecule to 
diffuse a specific distance increases as a function of distance squared. So, doubling the 
distance quadruples the time. Thus, protein-protein interactions can reduce the distance 
between active sites of enzymes and increase the rate of flux of substrates through multistep 
reactions. In fact, there is good evidence that formation of supramolecular complexes within 
mitochondria increases the rate of oxidative phosphorylation (Boekema and Braun, 2007) 
and that proton antennae in neighboring proteins increase the speed of the astrocytic lactate 
transporter (Stridh et al., 2012). Formation of complexes also likely improves the specificity 
of some reactions within nanodomains of a cell. For example, interactions with a kinase or 
ubiquitin ligase might limit the number of proteins phosphorylated/ubiquitinylated upon 
activation.
Astrocytes have fine processes that contact ~100,000 synapses (Bushong et al., 2002; see 
Fig. 3A) and endfeet processes that ensheath arterioles and capillaries (Iadecola and 
Nedergaard, 2007). Thus much like neurons, astrocytes are likely polarized cells in which 
proteins are selectively sorted into these functionally distinct domains and assembled into 
multiprotein complexes. A few studies have identified proteins that interact with the Na+/K+ 
ATPase or with glutamate transporters (Genda et al., 2011; Rose et al., 2009; Bauer et al., 
2012). Since these proteins are enriched near synapses, this information may help us 
understand the functional properties of these nano-domains. Similarly aquaporin-4 is 
enriched in endfeet and forms complexes with other proteins (Nagelhus and Ottersen, 2013). 
Essentially nothing is known about the mechanisms involved in this sorting and there is still 
a lot to learn about the complexes that are formed in these nano-domains and their functional 
significance.
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Many interactions are identified by a hypothesis-driven approach: two proteins are found to 
functionally interact and one tests for protein interactions (for examples, see Robinson and 
Jackson, 2016). In many cases, antibodies are used to immunoprecipitate a protein of 
interest and Western blots are used to determine whether an interacting protein is found in 
the immunoprecipitate (Isono and Schwechheimer, 2010; Kaboord and Perr, 2008). With 
discovery-based strategies, novel interacting proteins can be identified, information which is 
used to generate and test hypotheses. Advancements in mass spectroscopy have made it 
relatively easy to identify proteins in immunoprecipitates. It is also possible to fuse a domain 
from a protein of interest to glutathione S-transferase (GST) with cloning strategies. The 
subsequent cDNA is then used to over-express the protein in bacteria, which is then purified 
and incubated with solubilized tissues of interest. Complexes are then isolated using 
glutathione-based affinity columns (Harper and Speicher, 2011). Variants of this strategy are 
used to test whether interactions between two proteins are direct and to map domains of 
proteins required for a given interaction. Finally one can use yeast two-hybrid based 
strategies to identify novel interacting proteins. Here, a domain from a protein of interest is 
fused to part of a transcription factor. Then, the hybrid is used to screen a library of target 
sequences fused to the rest of the transcription factor and interactions are identified as 
transcriptional activity (Ito et al., 2001). Candidates can be tested for co-localization in 
tissues or cells of interest, for example by looking for covariance (Li et al., 2004). If one or 
both of the proteins are widely distributed, it is possible to determine whether the observed 
overlap occurs more frequently than that which would occur by chance, by using Monte-
Carlo simulation, e.g. (Genda et al., 2011).
There are several issues with any of these approaches. First, it is at least theoretically 
possible that some interactions form after solubilization. This post-solubilization aggregation 
is likely due to either electrostatic or hydrophobic interactions and will increase linearly with 
protein abundance. Sequential rinses with buffers containing different concentrations of salt 
can reduce these physiologically irrelevant interactions. Second, antibodies used to 
immunoprecipitate a protein may directly bind to and precipitate non-specific targets. This 
can be partially addressed by performing ‘reverse immunoprecipitations’ with an antibody 
against the putative interacting protein. Third, the GST and yeast 2-hybrid approaches 
require guessing where potential interacting proteins might bind. Fourth, there are several 
different types of detergents, including non-ionic, bile acid salts, ionic, etc. One needs to 
empirically identify the detergents that best solubilize the protein of interest and reduce non-
specific binding of proteins in the lysate (for reviews, see Le Maire et al., 2000; Phizicky 
and Fields, 1995; Garavito and Ferguson-Miller, 2001; Seddon et al., 2004).
It is ultimately important to rigorously demonstrate the relevance of an interaction in vivo. 
Super-resolution microscopy has been improved to the point that the resolving power is in 
the 10 to 50 nm range. Although this resolution is not sufficient to demonstrate direct protein 
interactions, it can support the notion that two proteins exist in the same nanodomain. 
Mapping domains required for an interaction allow for generation of constructs or peptides 
that will function as dominant-negative inhibitors of the interaction. Of course, if multiple 
‘interacting’ proteins are identified, we must guess which proteins form direct interactions; 
this is a daunting task because there may be many proteins in a supramolecular complex. For 
example, the post-synaptic density has about 2,000 proteins (Focking et al., 2016). It is also 
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possible to test for interactions by labeling two putatively interacting proteins with different 
fluorescent tags. One of the fluorophores is excited and energy is transferred to a second 
fluorophore by resonance. This technique is called intermolecular Förster resonance energy 
transfer (FRET) and only detects proteins that are within 10 nm of each other (Sekar and 
Periasamy, 2003; Jares-Erijman and Jovin, 2003; Pietraszewska-Bogiel and Gadella, 2011).
B The players: function of enzymes and transporters
B.1 Enzyme activity—Once the location and abundance of an enzyme have been 
established, the question of function is next to arise. To assess the specific activity of an 
enzyme time-dependent changes in the concentration of the substrate (or product) need to be 
determined, during the steady state, in tissue/cell homogenates under specified conditions 
(Lorsch, 2015), and at a wide range of substrate/ligand concentrations to obtain the main 
kinetic parameters: half-saturation or Michaelis constant (Km), half-inhibition constant (Ki), 
maximal velocity constant (Vmax) and turnover number (kcat; Purich, 1979; Purich, 1980; 
Purich, 1982; Brooks et al., 2004). This is essential when predicting metabolic fluxes 
controlled by enzymes according to substrate concentrations (Kaplan and Colowick, 1955; 
Herrero-Mendez et al., 2009), tissue damage (Adan et al., 2016) or drug discovery (Widder 
and Green, 1985; Zhang, 2017).
The specific activity of enzymes is a very useful measurement, and is necessary for 
understanding the functional fraction. This is important for enzymes that, for instance, are 
highly susceptible to oxidation of key cysteine residues leading to inactivation, such as 
mitochondrial respiratory chain complexes (Bolanos et al., 1994; Bolanos et al., 1995). 
Subcellular fractionation followed by enzymatic analysis represents a good strategy for 
estimating specific activity within the natural environment (Murphy and Chan, 2014). The 
development of techniques for the use of in-gel activity assays for proteins in their native 
tertiary/quaternary structures, such as blue-native gel electrophoresis followed by NADH 
dehydrogenase activity for mitochondrial complex I (Murphy and Chan, 2014; Lopez-Fabuel 
et al., 2016) may also represent progress towards the characterization of enzyme activities in 
their natural conformation.
The main drawbacks of enzymatic analyses are technical and of interpretation. Technically, 
the unfeasibility of detecting the substrate or the product forces that couple enzymatic 
reactions (Purich, 1982), although the product of which - usually NAD(P)H- can be easily 
determined. Whereas coupling often represents the only available approach for assessing the 
specific activity of an enzyme, it often generates parasitic reactions (Auld and Inglese, 2004) 
that mask, usually by overestimation, the actual enzyme activity. When the limitation is due 
to the low sensitivity of the method to detect the substrate/product, alternative approaches 
can be implemented to enhance sensitivity. Often, the use of fluorescent, luminescent and 
radiometric detection methods can overcome the sensitivity problems (Purich, 1980; 
Simeonov and Davis, 2004; Dahlin et al., 2004), although they require the use of more 
complex equipment and expensive probes. Kinetic parameters of enzymes responsible for 
post-translational changes in proteins are difficult to assess as they require more tedious 
analyses such as Western blotting followed by semi-quantitative estimation of the modified 
substrate (e.g., phosphorylation, ubiquitination, acetylation, etc; Glickman, 2004), hence 
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complicating the accurate knowledge of the kinetic parameters of the enzyme. Another 
limitation of this technique is the absence of the physiological environment of the enzyme 
when its activity is determined. Kinetic parameters of enzymes are determined by adding 
cofactors and substrates to the reaction mixture at concentrations that might be far from the 
physiological concentrations in the cell, especially if saturating concentrations are used for 
determining Vmax. Furthermore, the specific cellular or subcellular localization of enzymes 
is not reflected in the reaction mixture, although efforts should be made to mimic the in-cell 
conditions (Dahlin et al., 2004). For enzymes that are naturally membrane-bound, the use of 
detergents may help solubilize the protein for easier access of substrates and cofactors, but 
very often the detergent interferes with light, fluorescent or luminescent detection methods 
(Simeonov and Davis, 2004). When the detergent cannot be used, due to interferences, the 
insolubilized membranes cause light scattering, which may preclude spectrophotometric 
analyses (Brooks et al., 2004). Finally, the specific activity, which represents maximal 
activity, gives no information about the influence of other enzymes of the pathway on the 
metabolic flux (Almeida et al., 2004). A well know example is hexokinase, which under 
physiological conditions work at 10% of its maximal activity, as it is tonically inhibited by 
its product glucose-6-phosphate (Wilson, 2003).
B.2 Activity of transporters and channels: tracers, fluorescence and 
electrophysiology—The widespread availability of radioactive tracers at the dawn of the 
nuclear age led to detailed kinetic understanding of several membrane transporters, well 
before their molecular identification. For practical reasons, the best characterized 
transporters were (and still are) those expressed in erythrocytes, in particular the facilitative 
hexose transporter GLUT1 (LeFevre, 1948; Widdas, 1954), later found to dominate the 
glucose permeability of endothelial cells, astrocytes and oligodendrocytes. Radioactive 
indicator-dilution assays were developed for in vivo studies in animals that allowed the 
kinetic characterization of the transport mechanisms at the blood-brain barrier (Crone, 1965; 
Yudilevich and Sepulveda, 1976). In human, brain glucose transport parameters could be 
estimated by combining steady-state measurements of parenchymal glucose concentration 
obtained by MRS, microdialysis and microelectrodes, with mathematical modeling (Gruetter 
et al., 1998; Barros et al., 2007). Decades of radiotracer experiments in cultured cells and 
heterologous expression systems have shown that the selectivity and kinetic properties of 
transporters for energy metabolites such as glucose, lactate, pyruvate, glutamate and 
glutamine are insensitive to cellular context. What is less well understood is their regulation, 
that is, if and how the intrinsic activity and subcellular localization of the transporters 
responds to the large changes in metabolic demand that accompany neural activity. Excellent 
in terms of signal-to-noise ratio, radiotracer methods offer limited spatial and temporal 
resolution, which precludes the study of single cells, complex tissues or rapid regulatory 
phenomena. In the case of H+-coupled monocarboxylate transporters (MCTs), the carriers of 
lactate, pyruvate and ketone bodies, indirect single-cell characterization has been possible by 
means of intracellular pH electrodes or pH-sensitive dyes like 2',7'-bis-(2-carboxyethyl)-5-
(6)-carboxyfluorescein (BCECF; Single cell glucose transport determination is possible with 
the fluorescent glucose analogs 6- and 2-([N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-
deoxy-D-glucose; (6-NBDG and 2-NBDG; Speizer et al., 1985; Yoshioka et al., 1996). They 
are twice as big as glucose, and are therefore taken by GLUTs at a lower rate (Barros et al., 
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2009a), a property that can be taken advantage of to achieve real-time measurement of 
transport activity and thus detect fast regulatory changes (Loaiza et al., 2003; Porras et al., 
2004; Porras et al., 2008). Detected by confocal microscopy in brain tissue slices or by two-
photon microscopy in vivo, they have served to estimate the contribution of neurons and 
astrocytes to the uptake of sugar (Barros et al., 2009b; Jakoby et al., 2014; Chuquet et al., 
2010). Presently, their performance has been surpassed by that of genetically-encoded 
fluorescent sensors (Section C.3), which provide a stronger signal and a direct readout of the 
metabolite of interest, avoiding the need for assumptions and controls about analog handling 
by transporters and enzymes.
A substantial fraction of the brain´s ATP turnover is associated with the recovery of ion 
gradients dissipated by ion channels during synaptic activity (Harris et al., 2012). In 
addition, many metabolites possess a net charge and recent studies in glial cells have 
indicated that some of them may be transported by ion channels (Sotelo-Hitschfeld et al., 
2015; Karagiannis et al., 2016). This makes electrophysiology an important tool not just for 
the manipulation but also for the understanding of brain energy metabolism. The electrical 
properties of brain cells are typically studied in acute tissue preparations and in cell cultures. 
In contrast to neurons, which are characterized by action potentials, glial cells have no swift 
electrical events taking place across their membranes. In addition, the plasma membranes of 
astrocytes and oligodendrocytes are extremely leaky due to high background activity of 
potassium channels. There are also no fast excitatory or inhibitory synapses on astrocytes or 
oligodendrocytes and therefore stimulation of an afferent pathway commonly used for 
activation of neurons cannot be used to synchronously “fire” them. For these reasons 
electrical recordings are less commonly used in studies of these cells. Recordings with 
extracellular electrodes can detect stimulus-evoked compound action potentials, CAPs (Stys 
et al., 1991), where changes in the extracellular ion distribution due to glial transporters do 
play a role, but it is very hard to separate the glial component from the contributions of other 
tissue elements. From the metabolic point of view, the in vitro recording of CAPs offers the 
advantage that the tissue can be maintained for extended periods in a perfusion chamber 
with temperature, degree of oxygenation and nutrient supply controlled by the experimenter. 
In a homogeneous tissue such as the optic nerve, the CAP represents the response of a 
common neural cell type, central white matter myelinated axons. However in less 
homogeneous tissue e.g. the hippocampus, the recorded response is from heterogeneous cell 
types is recorded, thus the response may not be a true reflection of the contribution of 
individual neural cell types (Cater et al., 2001; Brown et al., 2003). In vitro recordings of 
acutely isolated tissue may be problematic with regards to the diffusion barrier created by 
large pieces of tissue, where inadequate diffusion of oxygen and glucose may lead to anoxic 
and/or hypoglycemic conditions at the center of the tissue (Tekkok et al., 2005).
Recordings with sharp glass electrodes are possible for large glial cells (Deitmer, 1992). 
Intracellular recordings in patch-clamp mode seem to be more suitable for studies of 
astrocytes, which are usually much easier to patch than neurons in spite of their small size. 
Using the patch clamp approach it is possible to perform an accurate pharmacological 
characterization of receptors expressed by astrocytes (Lalo et al., 2008; Palygin et al., 2011). 
However, such experiments work best when astrocytes are isolated because it is not always 
easy to localize the site of action of the drugs when applied to tissues. Experiments in vitro 
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allow tight control of the perfusion media including concentration of metabolites and drugs 
and the recordings are much more stable. However, astrocytes are very sensitive to stress, 
which is inevitable during preparation of slices and they easily convert to a “reactive” 
phenotype that may have a somewhat different physiology to the naïve cells in situ. In 
addition, metabolic conditions in a slice never correctly mimic conditions in vivo. Most 
acute slice experiments are performed in solutions bubbled with 95% O2/5% CO2 mix, 
resulting in hyper-oxygenation of the superficial cells. For some experiments this is a 
problem, as shown for example in studies of neuro-vascular coupling where the O2 level was 
eventually reduced to 20% (Hall et al., 2012). However, using lower oxygen can easily lead 
to hypoxia in the center of a moderately thick slice (300 µm). In a similar vein, virtually all 
standard slice work is performed in solutions containing 10 mM glucose or more, while 
brain tissue glucose is about 1mM (Barros et al., 2017). This overloads superficial astrocytes 
with glucose. Finally, cultured astrocytes are ideally suited for patch recordings but culturing 
affects the morphology, physiology and metabolism of these cells, factors that can be 
ameliorated by co-culturing with neurons (Mamczur et al., 2015; Hasel et al., 2017). In 
summary, patch clamp is perhaps the best electrophysiological approach for studying 
astrocytes, but caution is required when extrapolating from data obtained on isolated 
astrocytes. It should also be remembered that while recording with patch electrodes, we 
artificially impose on the cell our ideas about the intracellular concentration of ions and 
metabolites because pipette solutions rather quickly dialyse into the astrocyte. Thus, our 
conclusions about the currents in these cells are only as accurate as our knowledge of their 
native intracellular ion composition.
B.3 Optogenetic actuators: manipulating metabolism—Optical control of electrical 
and signaling events in brain tissue in situ is in principle highly attractive because it seems to 
be non-invasive, fast and can be targeted to individual cells and cellular populations. 
Although light-sensitive proteins that affect cellular functions in plants have been known of 
for a long time, a major shift in neuroscience took place around 2003–2006 when it was 
demonstrated that such proteins can be expressed in mammalian neurons and used to 
activate them (Nagel et al., 2003; Boyden et al., 2005; Bi et al., 2006). Channelrhodopsin-2 
(ChR2), which was (and still is) the most popular member of this family behaves as a light-
gated channel permeable to sodium, potassium, protons and Ca2+. Manipulating sodium 
conductance presents an obvious way to depolarize neurons and trigger action potentials on 
demand. This is by far the most common use for this protein, which can be targeted to 
specific populations of cells using molecular and genetic approaches, and it will be very 
interesting to exploit it to investigate the role of specific neurons on local energy 
metabolism. ChR2 has also been used to activate astrocytes (Fig. 3F; Gourine et al., 2010), 
where it triggered Ca2+ elevations, though this required an application of several seconds of 
pulsing blue light (NB: constant blue light is a notorious source of artifacts). The Ca2+ 
increases were largely dependent on thapsigargin-sensitive internal Ca2+ stores (Figueiredo 
et al., 2014; Perea et al., 2014). ATP release was also documented from ChR2-stimulated 
astrocytes (Gourine et al., 2010). Many studies in the meantime have used ChR2 to activate 
astrocytes, though it should be noted that this is not an ideal tool for controlling these cells. 
A significant Na+ influx most likely affects multiple Na+-dependent transporters on 
astrocytes and the downstream effects become hard to disentangle. Prolonged ChR2-
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mediated activation leads to acidification of astrocytes due to a build-up of lactate (Tang et 
al., 2014). Since ChR2 does not mimic any obvious endogenous physiological mechanism 
operating in astrocytes, it is reasonable to explore alternatives. Attempts to use exotic 
approaches such as the light sensitive proton pump Arch have also been made (Poskanzer 
and Yuste, 2016; Beppu et al., 2014), but the actions of this protein on astrocytes are even 
less clear than those of ChR2. Light-activated G-protein coupled receptors (GPCR) have 
been used (Tang et al., 2014) with the assumption that via this route events can be evoked 
that are similar to the native signaling in the brain where astrocytes are mainly controlled via 
GPCRs. These constructs however need to be used with caution because, when expressed at 
high level, GPCRs have a tendency to signal without any external trigger. Thus, 
overexpression, commonly used in many experiments, can be seen as a problem. An 
interesting new approach is to use a dimerization strategy for optical activation of signaling, 
for example activities of kinases. For astrocyte research a construct has been introduced that 
triggers Ca2+ entry via the ubiquitous CRAC channels (Kyung et al., 2015). Even though 
this tool may not be fast enough for triggering really rapid events, it seems that for many 
cases it can be advantageous, because at least it is a clearly defined mechanism for 
increasing astrocytic Ca2+. To summarize, the use of optogenetics for the study of brain 
energy metabolism is just starting, with a promising future of ever more specific and 
powerful ways to manipulate individual cells.
C. The play: metabolite concentrations and fluxes
C.1 Respirometry—Neural activity is tightly coupled to local fuel oxidation. The oxygen 
consumption rate (OCR) is therefore highly valuable information when characterizing 
cellular bioenergetics or diagnosing diseases. After decades of productive use for research 
and teaching, the estimation of oxygen consumption with manometry (Warburg, 1928) was 
superseded by easier and more accurate, real-time determinations by using polarography 
(Clark et al., 1953). Whilst the traditional Clark-type electrode has delivered most of our 
current knowledge of mitochondrial bioenergetics, it has disadvantages (Zhang et al., 2012). 
Oxygen often leaks from the chamber through junctions and holes used for the 
administration of drugs and inhibitors; assembly of the equipment is tedious, time 
consuming and requires frequent calibration; the electrode is easily oxidized or damaged, 
and thus has a short lifespan; the need for continuous stirring to mix the cell or 
mitochondrial suspension usually harms the sample, in particular when analyzing isolated 
intact mitochondria; and since several of the inhibitors used to characterize the contribution 
of mitochondrial complexes to oxygen consumption are lipid soluble, the chamber needs to 
be thoroughly washed between samples. Whilst the chamber size is often fixed, the internal 
volume can be adjusted between 0.3–2 ml. However, the best results are often obtained with 
large sample volumes (usually, 1 ml), thus requiring large amounts of biological material for 
the analysis. This makes the system unsuitable for screenings. The appearance of multiwell 
plate respirometers has fired up the field (e.g. Agilent technologies/Seahorse Bioscience, 
Presens). These devices are built to simultaneously determine OCR and extracellular 
acidification rate (ECAR) in 24- or 96-well plates of adherent rather than suspended cells. 
OCR is determined using an oxygen-sensing fluorophore instead of the traditional oxygen-
consuming electrode, and ECAR, with a pH sensor. Though popular, the high cost of both 
the instrument and the single-use plates are a disadvantage. In addition, ECAR is often 
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thought to reflect glycolysis rate because the release of lactate acidifies the extracellular 
medium. However, caution should be taken because the CO2 released by the tricarboxylic 
acid activity significantly contributes to extracellular acidification (Mookerjee et al., 2015; 
Mookerjee et al., 2017). The Clark electrode and the fluorophore-based multi-well 
instruments are highly valuable tools for characterizing aerobic metabolism in biological 
samples. Choosing one or the other depends on sample type and on flexibility in the study 
design. For instance, the Clark-type electrode chambers are very useful when the sample 
size is not limiting, as it provides more accuracy and time resolution, but the method is time 
consuming, such that only a few samples can be assayed in a day. This approach is also 
suitable for tissue slices or isolated mitochondria in suspension, as well as intact or 
permeabilized cells in suspension. It should be noted that harvest of neurons from a culture 
dish for assay in suspension leaves behind the neuronal processes and the mitochondria 
within them. With both assay platforms, a large number of substrates, inhibitors or 
uncouplers can be used to better characterize the bioenergetics of the sample. Selective 
permeabilization of the plasma membrane allows control of substrate delivery to the 
mitochondria, and avoids the need for isolation of mitochondria from cultured cells 
(Divakaruni et al., 2014). The multi-well apparatus, in contrast, is very useful for accurate 
screenings in intact adherent cells, permeabilized adherent cells, or isolated mitochondria 
and requires a smaller sample size (around 1–3 × 104 cells/well or 1–3 micrograms of 
isolated mitochondria/well; Divakaruni et al., 2017; Rogers et al., 2011). This is particularly 
important when determining OCR in highly differentiated cells, such as neurons, given the 
low yield in these preparations. Note that multi-well respirometry is routinely employed in 
the absence of bicarbonate, a substrate of the anaplerotic enzyme pyruvate carboxylase and a 
regulator of astrocytic glycolysis (Ruminot et al., 2011). Multiwell respirometry is also 
constrained in terms of temporal resolution, with a typical rates integrated over 2–5 minutes. 
One limitation common to both oxygen electrodes and multi-well methods is the need for 
homogenous cell populations, which is not ideal for the study of brain cells, as neurons and 
astrocytes foster their mutual functional and metabolic differentiation (Barres et al., 1990; 
Mamczur et al., 2015; Hasel et al., 2017). A limitation of the use of isolated brain 
mitochondria in either apparatus is the fact that the mitochondria arise from multiple 
different cells types, thus specific information on the function of neuronal versus astrocytic 
mitochondria is lost in this approach. However, respirometry can be performed on 
preparations of synaptoneurosomes, which are resealed synaptic vesicles created upon 
homogenization of brain tissue that contain mitochondria from synaptic terminals (Choi et 
al., 2009).
C.2 Extracellular microdialysis and enzyme-based probes—Given that the 
interstitial fluid is the medium of exchange between blood, the cerebrospinal fluid and the 
intracellular compartments of neuron and glia (Ransom, 2009), the ability to measure 
interstitial metabolites is crucial. However, the space left between brain cells is only 20 nm 
wide, which makes probing its composition a major technical challenge. Dialysis probes 
have been used to measure metabolic substrates from awake, moving animals (Brown et al., 
2011). Placement of the dialysis probe requires complex surgery from which the animal 
recovers. The probes can be permanently attached to the animals’ skull with the sensing 
component extending into the brain parenchyma. The probe is guided through the brain 
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parenchyma until a desired location is reached, which creates considerable localized damage 
and forms a 3rd space that fills with the contents of damaged cells, and whose composition 
clearly does not represent the baseline interstitial fluid. However this perturbation dissipates 
over time as local repair mechanisms tend to normalize the 3rd space contents. The 
interstitial fluid is sampled by applying backpressure, such that a small volume is drawn up 
into the probe (5–10 µl) to be later analyzed by HPLC. Repeated samples can be withdrawn 
over extended periods of time (days to weeks) thereby facilitating longitudinal studies. 
Advantages of this technique include its use for extended periods and the accuracy of HPLC 
analysis. Some disadvantages are that it does not provide real-time information, it disrupts 
the tissue, has low spatial resolution. It is a hotly debated area whether the samples reflect 
the real environment in the interstitial space.
Real-time measurements of brain interstitial fluid can be obtained with enzyme-based 
microelectrodes. Probes can be as fine as 7 µm in diameter with the active tip between 100 
and 500 µm in length. The greater the surface area of the tip the greater the temporal 
resolution. Such probes are useful for recording from homogeneous brain structures such as 
isolated optic nerve (Yang et al., 2014b) and hippocampus (Fig. 3E; Newman et al., 2011; 
Frenguelli et al., 2003). However, as the probe records the aggregate signal from the entire 
tip area, care should be taken in interpreting data acquired from brain areas with 
heterogeneous cell populations. Those probes currently available can sense a multitude of 
compounds of interest to metabolic studies, including ATP, adenosine, acetylcholine, 
glucose, lactate, D-serine, choline, glutamate. The sensors can be calibrated prior to the 
experiment and are thus able to provide real-time estimates of concentrations, and they can 
be used for both in vivo and in vitro studies. A great advantage of modern commercially 
available sensors is that several probes may be used simultaneously to measure the 
concentrations of multiple metabolically relevant compounds e.g. glucose and lactate, ATP 
and adenosine (Fig. 3E; Frenguelli et al., 2007; Newman et al., 2011). Microsensors can be 
used in parallel with other real-time techniques, e.g. electrophysiology (Brown et al., 2012; 
Yang et al., 2014b) and genetically-encoded intracellular nanosensors (Machler et al., 2016). 
The power of combining functional assays with the real-time measurement of metabolic 
substrates has proven to be very effective in determining key processes in both grey and 
white matter.
C.3 Genetically-encoded fluorescent nanosensors for metabolites—Metabolite 
nanosensors are chimeric proteins that change their optical properties upon binding a ligand 
(Tsien, 2009; Fehr et al., 2003). Their specificity is conferred by a recognition domain, such 
as a bacterial periplasmic protein or a transcription factor, and their fluorescence by one or 
two fluorescent proteins, such as GFP, mTFP or Venus. Many of them are based on 
intramolecular FRET. Expressed in cellular compartments, the nanosensors are detected by 
microscopy: wide field, confocal or two-photon. In brain cells, measurements have been 
reported for glucose, glutamate, ATP, ATP/ADP, NADH/NAD+, lactate and pyruvate, 
reviewed in San Martín et al., 2014b. Most sensors are easily available through the non-
profit repository Addgene. The main strength of these tools is resolution, which for high-end 
microscope setups is in the order of seconds and micrometers. Thus, they provide a real-time 
estimation in single cells. Being genetically-encoded, they can be targeted to organelles and 
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subcellular domains (Pendin et al., 2017). Their most common and robust use is to report 
metabolite fluctuations in before-and-after experiments, for example when characterizing the 
effect of a physiological or pharmacological perturbation (e.g. see Fig. 3G). Using standard 
transfection or viral expression systems, sensor concentration is about 10 µM (Miyawaki et 
al., 1999), which is lower than the physiological concentration of most metabolites and 
therefore metabolite sequestration and slow dissociation kinetics are not usual concerns. An 
important exception is NADH, which is in the nanomolar range.
As they are proteins, nanosensors are potentially susceptible to their physical environment. 
Some of the early versions were sensitive to pH, which could be corrected by parallel pH 
measurements. Their main weakness is that they are difficult to calibrate. One important 
caveat, which is not always explicit, is that it is not safe to draw conclusions from 
differences in intensity between cells. Even for FRET-based and other ratiometric sensors, 
the readout is affected to some extent by expression level due to non-linearities in the optical 
path. To compare cells, a calibration is therefore required. The simplest one-point calibration 
is achieved by forcing a reading at one end of the binding curve (i.e. zero or saturation) and 
then using the affinity constant and maximum fluorescence change determined in vitro to 
extract concentrations by interpolation (Barros et al., 2014). If both ends of the saturation 
curve are accessible, a more robust two-point calibration protocol becomes feasible, where 
only affinity needs to be assumed as shown for the pyruvate sensor (San Martín et al., 
2014a). Avoiding assumptions by recurring to a full in situ calibration is possible (Bittner et 
al., 2010) but is seldom practical, as it demands harsh permeabilization and/or metabolic 
inhibition procedures that may perturb the sensor itself. When quantitative data are available, 
nanosensors may be used to measure absolute flux by means of inhibitor-stop protocols 
(Bittner et al., 2010; San Martín et al., 2013; San Martín et al., 2014a). As both calibration 
and quick transporter inhibition are needed, this kind of assay is currently restricted to cells 
in culture and in slices. Inhibitor-stop methods assume that there is no quick adaptation to 
the inhibition, which has to be evaluated on a case-to-case basis.
Nanosensing is an emerging technology and probes for other metabolites are surely on their 
way. One example is a sensor for NADP+ (Cameron et al., 2016), which may help in 
tackling the cryptic pentose phosphate pathway (Bouzier-Sore and Bolanos, 2015). In 
parallel, existing sensors are being improved and extended in terms of brightness, affinity, 
dynamic range and spectra (e.g. red-shifted for deeper tissue penetration by reducing 
scattering). One important objective at hand is the generation of extracellular sensors to 
approach the brain interstice in non-invasive manner.
C.4 In vivo optical imaging: from autofluorescence to genetically-encoded 
sensors and transgenic animals—Brain energy metabolism has been the focus of 
studies since optical imaging methods began in the 1960s (Chance et al., 1962), where 
changes in tissue UV autofluorescence observed upon altering respiration in vivo were 
interpreted as changes in the NAD+/NADH ratio (Mayevsky and Chance, 1975). This and its 
relative flavoprotein autofluorescence imaging have been widely applied (Shibuki et al., 
2003; Weber et al., 2004; Shuttleworth, 2010; Reinert et al., 2011; Kasischke et al., 2004). In 
the early reports, the dynamics of hemoglobin oxygenation was discussed, a phenomenon 
that was later exploited by Grinvald and colleagues to map brain activity (Malonek and 
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Grinvald, 1996), and which paved the way for the development of blood oxygenation level 
dependent (BOLD) fMRI (Ogawa et al., 1990). Oxy- and deoxyhemoglobin can be 
discerned optically due to their differential absorption spectrum. However, the intrinsic 
optical contrast mechanisms have only marginally helped to generate mechanistic insight 
into cell-specific metabolic processes, because the signals are difficult to discriminate from 
each other, and hard to quantify and interpret (see Box 1). After their successful use in 
cultured cells and brain tissue slices (Section B.4), fluorescently labeled substrates were 
used to investigate energy metabolism in combination with two-photon microscopy (Denk et 
al., 1990; Zipfel et al., 2003). Using the non-metabolized fluorescent glucose analog 6-
NBDG, an acute increase in glucose uptake was detected in astrocytes but not in neurons of 
the somatosensory cortex of stimulated rats (Chuquet et al., 2010). However, the optical 
properties of NBDGs are not favorable because of a very low two-photon cross-section. 
Alternative fluorescent glucose analogues were developed (Kovar et al., 2009; Tian et al., 
2009) and used in vivo (Lundgaard et al., 2015), but the data remain difficult to interpret 
because some are hardly transported due to high molecular weights of 1.3 kDa (Kovar et al., 
2009; Lundgaard et al., 2015). The advent of genetically encoded sensors for energy 
substrates (Section C.3) promises to be a significant advance for the field of brain energy 
metabolism, as they offer cellular resolution and real-time measurements (Fig. 3G; 
Lerchundi et al., 2015; Sotelo-Hitschfeld et al., 2012; Machler et al., 2016). In combination 
with advanced viral expression vectors and hopefully transgenic mice (see below), these 
sensors are particularly well suited for in vivo research using two-photon microscopy. 
Quantitative measurements of partial pressure of oxygen (pO2) in vivo can be obtained with 
phosphorescence lifetime imaging microscopy (PLIM), in which a phosphorescent dye 
produces a decaying light signal after a short illumination. This decay is shortened by the 
presence of oxygen and its half-life can be translated to pO2 in absolute units. New 
phosphorescence probes were recently developed that can be two-photon excited (Esipova et 
al., 2016; Esipova and Vinogradov, 2014), which greatly widens the range of in vivo 
applications (Lecoq et al., 2011; Lyons et al., 2016; Parpaleix et al., 2013; Sakadzic et al., 
2010; Sakadzic et al., 2011). Until recently, high resolution imaging was only possible in 
anesthetized animals. A general concern for in vivo optical imaging and in vivo 
experimentation are the effects of anesthesia on metabolic processes. For this reason, an 
increasing number of laboratories are now using head-restrained awake rodents even with 
two-photon microscopy at single cell resolution.
Transgenic animals for metabolic imaging: The study of brain structure and function has 
been significantly facilitated by the availability of transgenic reporter animals, from 
nematodes to mammals, contributing for example, to the discoveries of the neurogenic 
potential of embryonic glia (Malatesta et al., 2003) and microglial motility (Nimmerjahn et 
al., 2005). More recently, genetically encoded sensors have been used as biosensors to 
visualize transmitter- and behavior-evoked Ca2+ signals (Akerboom et al., 2012; Paukert et 
al., 2014). In transgenic animals the sensors are expressed permanently at constant levels 
over generations, a distinct advantage over viral transduction, which requires injection of 
each animal, with the possibility of tissue injury and inflammation. In addition, transgenesis 
provides a higher degree of flexibility regarding cell-specific expression and size of the 
reporter construct. The generation of transgenic mammals is however time consuming, labor 
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intensive and expensive. Another important drawback is the scarcity of appropriate 
promoters to reach sufficient expression levels in specific cell types, but strategies have been 
developed to address these limitations (Hirrlinger et al., 2009; Madisen et al., 2015). To our 
knowledge there are only two transgenic mouse models to measure metabolites in brain 
tissue at this time: one that ubiquitously expresses a nanosensor for pyruvate (Bulusu et al., 
2017) and the other specific for neuronal ATP (Fig. 3G; Trevisiol et al., 2017). The pyruvate 
sensor was used to reveal the spatiotemporal dynamics of tissue explant glycolytic activity 
during development and the ATP sensor allowed imaging, for the first time, of the 
frequency-dependent energy demand of optic nerve axons.
The age of metabolism studies using transgenic animals is just beginning. Novel genetic 
tools such as CRISPR/Cas9 (Cong et al., 2013; Wang et al., 2013) facilitate particularly the 
generation of mouse lines with loxP-flanked transcriptional "stop" sequences followed by 
nanosensors targeted to a single well-defined gene locus (e.g. at ROSA26). Combinatorial 
breeding of mice with expression of inducible and cell-specific Cre-DNA recombinase and 
ROSA-nanosensor mice will provide promising opportunities to explore the many facets of 
energy metabolism in the mammalian brain. Transgenic C. elegans and D. melanogaster 
lines have been generated that express an ATP sensor (Tsuyama et al., 2013). Recently, fruit 
fly lines selectively expressing pyruvate and glucose sensors in mushroom body neurons 
helped to show that energy metabolism can play an instructional role in long-term memory 
encoding (Plaçais et al., 2017), a role that appears to extend to behavior (Li-Byarlay et al., 
2014). Another fruit fly study expressed a glucose sensor to characterize the delivery of 
glucose to brain cells (Volkenhoff et al., 2017). Short life cycle, relatively inexpensive 
experimentation and the availability of powerful tools for genetic manipulation, renders 
worms and flies very attractive for comparative studies of brain energy metabolism using 
imaging probes.
C.5 2-deoxy-[14C]glucose and [18F]fluorodeoxyglucose methods for the 
measurement of local glucose utilization—2-Deoxy-D-glucose (2DG) is an analogue 
of glucose (a hydrogen atom replaces the hydroxyl group on the second carbon) and this 
single structural difference is responsible for the chemical properties that make 2DG so 
suitable for the measurement of the rates of glucose utilization in the brain in vivo. 2DG is 
transported in the cell and metabolized qualitatively like glucose but only through the first 
step of the glycolytic pathway to provide 2DG-6-phosphate (2DG-6P). Since 2DG-6P is not 
metabolized further to a significant extent, its rate of accumulation is proportional to the 
amount of glucose used by the cell. Using an appropriate mathematical model of enzyme 
kinetics and [14C]-labeled 2DG associated with autoradiography (a technique using X-ray 
films to visualize radioactive molecules with a spatial resolution of approx. 50 µm), the 
[14C]-2DG method provides quantitative metabolic maps (in µmol of glucose/g/min) of the 
brain in which regions of altered activity can be easily visualized (Sokoloff et al., 1977). 
This method can be used in different species, yields massive amounts of data and has 
provided unequivocal evidence that energy metabolism is linked to local functional activity. 
This method was adapted for use in humans with [18F]fluorodeoxyglucose (FDG) and a 
positron emission tomography (PET) scanner (Reivich et al., 1979), which remains useful as 
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a tool for mechanistic investigation of brain energy metabolism in animals (Zimmer et al., 
2017).
Absolute quantification of glucose utilization is possible thanks to the use of 14C-2DG, but 
many laboratories lack authorization to work with long life radioactive isotopes. The 
operational equation based on the original model requires plasma glucose (glucose oxidase 
method) and [14C]-2DG concentrations (liquid scintillation counter) to be sampled 
frequently during a 45-min period, for which intravenous and intra-arterial catheters are 
inserted. While this is feasible in large animals, this can represent a technical limitation in 
mice, the choice animal model in the neurosciences. Also, the method requires that the brain 
of the animal is processed for autoradiography soon after completion of the experiment. 
Therefore only one measurement is possible per animal. The brain is cut entirely into 20 µm-
thick sections with a cryostat and dried sections mounted on coverslips are left in contact 
with an X-ray film or phosphor screens. After exposure data can be read out with means of a 
specific image analysis system or phosphor-imager. The method cannot measure individual 
cells so that it is not possible to separate, for example, the contribution of neurons and glial 
cells. 2DG and to a larger extent FDG (high electronegativity of the fluorine-18 atom) do not 
have the same affinity as glucose for either glucose transporters or hexokinase. For 
quantitative analyses, these differences must be corrected for by the lumped constant, a 
parameter present in the operational equation used to determine the local rate of cerebral 
glucose utilization. While the operational equation has been thoroughly validated for its use 
in physiological conditions, it may not apply in specific pathophysiological conditions in 
which cardiovascular function or blood glucose levels are altered. FDG remains the most 
frequently used tracer in PET imaging, particularly for the detection and staging of tumors, 
in spite of the low spatial resolution of PET, the relative invasiveness of the method and the 
radiation dose due to the injection of [18F]-FDG. The use of fMRI-BOLD (see Box 1) now 
represents the gold standard to study the human brain at rest and during increased functional 
activity.
Even if the 2DG/FDG method cannot provide information on the fate of glucose 
downstream of the first hexokinase step, it is as yet the only one that provides quantitative 
measurement of local glucose consumption in various structures of the brain. The recent 
development of computerized procedures for the automatic acquisition and 3D 
reconstruction of postmortem autoradiographic volume images now permits voxel-wise 
statistical methods to 3D-analyze the differences in glucose use in different groups of 
animals (without a priori identification of Region-of-Interest), as is done in humans (Fig. 
3B; Dubois et al., 2010; Boussicault et al., 2014).
C.6 Magnetic Resonance Spectroscopy—Combined with MRI, MRS is a powerful 
technique that permits simultaneous visualization and quantification of dozens of 
metabolites contained in the brain area studied. The major advantage of MRS though is the 
possibility to obtain metabolic information in a non-invasive manner. Nuclear magnetic 
resonance arises from the interaction between atomic nuclei that possess an intrinsic angular 
momentum, or spin, and a magnetic field. This interaction is a very weak one that confers a 
low sensitivity on this technique, depending on the nucleus considered, the signal being 
stronger for 1H and much weaker for 13C, for example. Most of the in vivo studies are thus 
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1H-MRS. Metabolites are analyzed in a voxel, or volume of interest, located on the MR 
image acquired just before MRS (Fig. 3C). Accuracy is therefore strongly dependent on the 
immobility of the animal, which can be controlled by performing another MRI just after 
MRS. Anesthetic choice is also very important, especially for metabolic studies, since many 
drugs have an impact either on the vascular response or on metabolite contents (Horn and 
Klein, 2010; Tchaoussoff et al., 1991). Note that only metabolites present at a concentration 
higher than 1mM may be detected by MRS. Moreover, spatial and temporal resolutions are 
rather low, for voxels are in the mm3 range, thus preventing discrimination at the cellular 
level, and, to get enough signal-to-noise ratio, acquisitions are performed over minutes 
rather than seconds. This temporal resolution is even lower with 13C-MRS, which has a 
detection level 4 orders of magnitude lower than that of 1H. Therefore, the use of 13C-
labeled precursor is a prerequisite to follow brain metabolism. 13C-labeled metabolites are 
infused in the blood circulation of the animal, at a rather high concentration, which leads to 
hyperglycemia with the main 13C-labeled precursor used, i.e. 13C-glucose, a point that is 
often neglected but has an impact when studying brain metabolism. Moreover, this labeled 
substrate, infused in the blood circulation, is not only metabolized by the brain but also by 
other organs, such as the liver for example, which may scramble the position of the 13C in 
some metabolites that go back to the blood and then to the brain, and thus complicates the 
analyses at the cerebral level. However, 13C-MRS is a powerful technique since the fate of 
the 13C can be followed and the exact labeled carbon positions of each detected metabolite 
can be determined and quantified, allowing the pathway taken by the 13C-labeled precursor 
to be traced back (Rodrigues et al., 2013; Rothman et al., 1999). Even if this technique does 
not reach cellular resolution, it can distinguish between a predominant neuronal or astrocytic 
metabolism. This is based on the principle that neurons and astrocytes differentially express 
some enzymes; e.g. glutamine synthase and pyruvate carboxylase.
Several approaches have been developed to overcome the low sensitivity of MRS. First, 
since the signal is directly proportional to the field strength, companies develop magnets 
with increasing magnetic fields. Secondly, the 13C weak signal can be detected by 1H-MRS 
using proton-observed carbon-edited (POCE) sequences. Finally, improved sensitivity for 
13C can be attained with polarization transfer experiments, which partly transfer energy from 
electron to nucleus, increasing the signal by 10,000 times, but only for some tens of seconds. 
Even if MRS is not a very sensitive technique, this relative weakness is also its strength, 
enabling NMR to study living organisms without significantly disturbing them and thus 
yielding detailed metabolic information non-invasively, which allows longitudinal studies 
(Stagg and Rothman, 2014; de Graaf, 2013).
In parallel to in vivo MRS, ex vivo NMR spectroscopy is also often used to explore details 
of brain metabolism (Fig. 3D). One of the biggest advantages of ex vivo NMR spectroscopy 
is achieving very high-resolution spectra and metabolic profiles. Spectra can be obtained 
either on perchloric acid extracts of cell cultures or tissues. Alternatively, with the use of 
special NMR probes such as HRMAS (high resolution magic angle spinning) it is now 
possible to achieve the same high spectral resolution on biopsies (without any biochemical 
treatment) as at obtained in liquid state NMR (extracts). The very recent development of the 
micro HRMAS probe (HRµMAS) allows for high quality spectra on nanoliter-sized samples 
(Duong et al., 2016). An important issue when performing ex vivo analyses is to completely 
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stop metabolism before acquiring the spectra. For cell cultures, the cellular layer is quickly 
rinsed with cold PBS (to avoid any contamination with medium metabolites) and cells are 
further either frozen with liquid nitrogen or directly extracted with perchloric acid. For brain 
biopsies, the only technique to avoid any post-mortem metabolism is to use focused 
microwaves. In less than one second, brain temperature reaches 70–80 °C, a temperature at 
which proteins are denatured and thus all enzymatic activities stop. The brain can be then 
taken out of the skull and a precise brain region can be either directly analyzed by HRMAS 
NMR spectroscopy or further processed with perchloric acid extraction of the metabolites 
for later liquid state NMR analyses.
The technical considerations described above are valid for all observed nuclei (1H, 13C, 31P, 
etc). For 13C, the use of 13C-labeled precursors is also needed (see in vivo spectroscopy 
paragraph). However, natural abundance can also be observed with ex vivo NMR 
spectroscopic studies, compared to in vivo studies, since long time acquisition (several 
hours) can be performed. Finally, the high spectral resolution of ex vivo NMR spectroscopy 
permits analysis of what is called homonuclear spin coupling. When several 13C are located 
on the same molecule, the resonance of the observed carbon is split and multiplets will 
appear. The analysis of these homonuclear spin-coupling patterns represents a unique 
advantage over other metabolic monitoring techniques such as radioactivity (Rodrigues et 
al., 2013).
C.7 Metabolomics, mass spectrometry and stable isotope tracing
Metabolomics: Cataloguing the complement of metabolites in a biological sample can lend 
important insight, particularly in the search for disease biomarkers. Mass spectrometry and 
proton NMR are generally the methods of choice for metabolomics (Dumas and Davidovic, 
2015). Proton NMR, a faster technique that can have a simpler sample preparation than mass 
spectrometry, measures metabolites in the low micromolar range, and has been used 
extensively in the characterization of CNS disorders (see Section C.6 and Oz et al., 2014), 
whereas mass spectrometry can detect picomolar and even femtomolar quantities of 
metabolites with time-of-flight and quadrupole time-of-flight detection systems. However, 
mass spectrometry typically involves a more complex sample extraction, derivatization of 
the metabolites to facilitate detection, and separation techniques prior to injection of a 
sample into the mass spectrometer. In general, methanol:chloroform extraction allows 
separation of polar and non-polar metabolites, and gas chromatography is used to further 
separate polar compounds, whereas liquid chromatography is used to separate non-polar 
metabolites. Following separation, the samples are ionized, and are separated and/or further 
fragmented in the mass spectrometer that detects the species based upon their mass/charge 
(m/z) ratio. Each metabolite generates its own pattern of peaks in the m/z spectrum, and the 
peak heights generally correlate with metabolite concentration. Huge quantities of data are 
generated by mass spectrometry, thus sophisticated systems biology data analysis tools are 
used to interpret the spectra, to detect differences between samples, and to define changes in 
patterns of related metabolites and metabolic pathways. Such approaches have been used to 
identify changes in the metabolome in a wide variety of neurodegenerative diseases in 
humans and in animal models (Dumas and Davidovic, 2015).
Barros et al. Page 19
Glia. Author manuscript; available in PMC 2019 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A particular challenge with metabolomics is to determine the meaning and significance of 
the multitude of findings with respect to cell and tissue health or to disease etiology. 
Relatively low throughput and intensive data analysis, as well as the high cost of state-of-the 
art LC- and GC-mass spectrometers present additional challenges. In metabolomics, spatial 
and subcompartmental information is lost except for the regional information provided by 
NMR-based spectroscopy. However, mass spectroscopy imaging is beginning to address 
cellular, and even subcellular resolution of metabolites using fluorinated nanoparticles in 
nanostructure-initiator mass spectroscopy and related approaches (Kurczy et al., 2015). If a 
metabolite concentration increases, it is unclear whether the change arises from enhanced 
production, or decreased consumption of the intermediate, as metabolomics is generally 
based on data gathered from a single snapshot-in-time. Thus, whether or not there are 
alterations in the flux of a metabolite through a metabolic pathway cannot readily be 
discerned. Computational flux balance can yield estimates of metabolic flux without 
labeling, but the approach is entirely reliant on existing knowledge of enzyme kinetics and 
pathways and thus has limitations (Aurich and Thiele, 2016).
Stable isotope tracing: By labeling and following carbon through metabolic pathways, 
stable isotope tracing can address questions regarding the extent and pattern of flux through 
metabolic pathways (Buescher et al., 2015). Stable isotope tracers are non-radioactive and 
naturally occurring, and are therefore safe. The technique is typically destructive to the 
sample to enable mass spectrometry, but can be performed on cultured cells, tissues, and in 
vivo. NMR can instead be used for detection, with a significant sacrifice in sensitivity 
(Rodrigues et al., 2013). 13C-containing molecules like glucose and glutamine have been 
used extensively, as the 13C in the parent molecule is transferred to downstream metabolites 
that can be detected by mass spectrometry (Fig. 3D). The extent to which metabolites 
become enriched with 13C combined with an analysis of the concentration of the metabolite 
is an indication of the flux through the metabolic pathway. The same, in principle, is true for 
15N- and 3H-labeled substrates. For isotope tracing with cells in culture, a full complement 
of growth media is typically added with replacement of a fuel like glucose with 13C-labeled 
glucose. The system is incubated for a sufficient time to allow the sample to come to 
isotopic steady state, and then the media is removed and the sample is extracted and 
derivatized for analysis by mass spectrometry. The spectral peaks for each metabolite are 
then used to quantify its abundance as well as the mass isotopomer distribution (the fraction 
of a metabolite enriched with zero, 1, 2, 3, etc 13C-labeled carbons). From these data, as well 
as separate experiments using other metabolic tracers, the extent of carbon flux from 
different substrates into the pool of a particular metabolite and its precursors can be 
calculated (Kelleher and Nickol, 2015). The ability to resolve cell-type specific metabolism 
in brain tissue or co-cultures is somewhat limited, and is reliant on either pharmacologic 
agents or genetic manipulation of isoforms of metabolite transporters or enzymes to control 
metabolism in particular cell types. Stable isotope tracing can determine the relative rates of 
flux of one labeled substrate versus another. Quantitative rates of flux can be determined by 
an extension of the technique termed metabolic flux analysis whereby the 13C-labeling 
pattern of intracellular metabolites is pinned to the rates of uptake and release of metabolites 
from a biological system. The data is applied to a computational network model of 
biochemical reactions that enables quantitative estimates of flux through specific pathways 
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(Buescher et al., 2015). The approach is more labor- and data-intensive than stable isotope 
tracing, and is reliant on a robust computational model that accounts for all potential 
reaction pathways.
Finally, in a particularly powerful approach, stable isotope tracing with mass spectrometry 
can be coupled with real-time measurements of metabolic flux using respirometry (a 
technique described in detail in Section C.1). The depth of insight provided by the 
combination of the two approaches is greater than either technique alone, and has been 
applied to the study of cultured cortical neurons (Divakaruni et al., 2017), the mouse retina 
(Du et al., 2016), and glioma metabolism and growth (Yang et al., 2014a).
C.8 Mathematical modeling—Mathematical modeling aims to integrate the outcome of 
multiple experimental techniques in order to grasp complex behaviors that are otherwise 
impenetrable. It serves to identify variables and parameters that are critical and should 
therefore be given experimental attention, to then guide the design of experiments by a 
priori, inexpensive visualization of possible outcomes. At its best, it may prefigure novel 
phenomena. In the specific case of brain energy metabolism, models combine structural 
parameters of brain tissue with the microscopic properties of enzymes and transporters in 
view of dynamic readouts obtained by technologies like PET, MRS, fMRI, tissue electrodes, 
microdialysis, and genetically-encoded nanosensors. A key well-substantiated assumption of 
current models is that metabolism is compartmentalized, that is, that it occurs in a few well-
mixed reservoirs (say neuronal and glial). Thus, chemical and transport reactions can be 
represented by a small set of ordinary differential equations that are solved by numerical 
simulation using standard computers. The outcome of a model is as good as what the model 
is fed, and so different groups have arrived at opposite conclusions: witness the astrocyte-to-
neuron lactate shuttle controversy (Hyder et al., 2006; Aubert and Costalat, 2007; Mangia et 
al., 2009; Jolivet et al., 2015). While debate speaks of a lively discipline, assumptions about 
key parameters are often hidden, and so it has been hard for the non-initiated to judge the 
relative merits of competing models (Jolivet et al., 2010). In view of structural, functional, 
and likely metabolic heterogeneity of neurons and glial cells (DeFelipe et al., 2013; 
Freeman, 2015), future models will have to become more complex, as has recently occurred 
for neuronal ATP subcellular domains (Le Masson et al., 2014). The next generation of 
models will also have to deal with growing evidence for fast local regulation of enzymes, 
transporters and channels in response to neural activity (Barros et al., 2013). However, it is 
important to understand that a more complex model (i.e. which include more equations and 
more parameters) is not necessarily better to adequately describe the different possible 
outcomes of a system. It all depends on the question(s) that need(s) to be addressed.
Concluding Remarks
The diversity, range and depth of the techniques applied to the study of brain energy 
metabolism are amazing, as is the complexity of the problem in hand. As we are now 
gaining access to the particular metabolic behavior of specific brain areas, cell types and 
even individual cells, techniques are becoming more and more sophisticated, each own 
having its own domain, strengths and limitations (Table 1). A challenge for the near future is 
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to increase the crosstalk between technical viewpoints, perhaps through the active exchange 
of ideas and collaboration between dedicated laboratories.
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Main points
- Brain energy metabolism in organized hierarchically
- Different organizational levels require different technical approaches
- Technical strengths and weaknesses are made explicit
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BOX 1
The BOLD-fMRI method: relationship with energy metabolism
MRI is well known for its capacity to non-invasively provide high resolution images of 
brain structures. MRI can also be rendered sensitive to local magnetic field 
inhomogeneity. This principle has been applied to develop the most common modality of 
fMRI, where the so-called Blood Oxygenation Level Dependent (BOLD) effect on 
magnetic field inhomogeneity is detected during brain activity. The BOLD effect relies 
on the local transient increase of the oxyhemoglobin-to-deoxyhemoglobin ratio during 
the haemodynamic response associated with neuronal activity (Ogawa et al., 1990). Since 
deoxyhemoglobin induces magnetic inhomogeneity, activated regions of the brain, with 
less deoxyhemoglobin, exhibit a stronger BOLD signal. BOLD-fMRI is either used with 
task-based paradigms, in which the mean of the baseline state is subtracted from the 
mean of the stimulated state to identify activated regions associated with the task, or it is 
used to study the brain at rest, in the absence of an explicit task (resting state BOLD-
fMRI; Gusnard et al., 2001). BOLD contrast fMRI has come to dominate the functional 
neuroimaging field.
The BOLD-fMRI signal is not a straightforward measure of energy metabolism. The 
deoxyhemoglobin content within a voxel is determined by the balance between the 
supply of oxygenated blood, the rate of oxygen consumption and the fractional blood 
volume. This is because the supply of oxygen is not matched precisely with the demand 
that the BOLD-fMRI signals change in regions where the actual amount of oxygen 
remaining in blood vessels is modified during activation. Hence, the BOLD response is 
dependent upon hemodynamic (blood flow and volume) and metabolic (oxygen 
consumption) responses. Although the value of BOLD fMRI for functional brain 
mapping is undisputed, the more subtle questions of how to interpret and use BOLD 
response magnitude and changes to derive information about energy metabolism are still 
unresolved. A reduction in the BOLD signal can result from a reduced neuronal 
activation, abnormal neuron/astrocyte coupling, a reduced vascular response, or a 
combination of all these components of the neurovascular response.
Quantitative fMRI techniques have been developed to measure the hemodynamic and 
metabolic responses to modulations in brain activity (Pike, 2012). They include arterial 
spin labeling (ASL) to measure variations in tissue perfusion in each pixel (which can 
help to disentangle confounding mechanisms), contrast agents to measure cerebral blood 
volume (CBV) and calibrated fMRI using biophysical models of the BOLD signal to 
estimate changes in the cerebral metabolic rate of oxygen consumption (CMRO2). 
Calibrated fMRI may be used as a biomarker of brain disorders that could be applied for 
therapy monitoring.
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Figure 1. Hierarchical organization of brain energy metabolism
Structural levels result from binding forces becoming weaker as small structures accrete into 
larger ones but also have an evolutionary explanation (Simon, 1962). The hierarchical 
organization of brain metabolism explains the success of reductionist investigative 
approaches.
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Figure 2. Technical domains in brain energy metabolism research
Different techniques perform over different domains, which are in turn defined by a 
combination of organizational level, experimental control and relevance to human 
physiology. For example, electrophysiology achieves excellent experimental control at small 
and intermediate hierarchies by in vitro recording from single channels, single cells or small 
cell assemblies, but it is not practical in vivo and cannot be used in humans. MRS, in 
contrast, may be applied to human subjects, but has limited experimental control and 
provides time- and space-averaged measurements.
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Figure 3. Examples of recent data in brain energy metabolism
A. Astrocytes in organotypic hippocampal slice culture were transfected with cDNA 
constructs encoding for hexokinase-ECFP and GLT1-mCherry using a gene-gun. B. In vivo 
[14C]-2-deoxyglucose uptake, obtained as described in Boussicault et al., 2014. C. 1H-MRS 
data obtained in a rat, at rest or during whisker stimulation. The difference between the two 
conditions reveals an increase in tissue lactate. The BOLD fMRI response was elicited with 
the same paradigm. D. Rat neurons in culture were exposed to 3-13C1 glucose so that the 
labeled carbon is lost via the PDH reaction but retained by the anaplerotic reactions of 
pyruvate carboxylase (PC) and malic enzyme (ME), from Divakaruni et al., 2017. E. 
Perturbation of hippocampal fuel fluxes during a memory task (adapted from Newman et al., 
2011). F. Lactate-mediated depolarization and firing of a neuron in the locus coeruleus after 
optogenetic stimulation of neighboring astrocytes (adapted from Tang et al., 2014). G. The 
graph show the biphasic response to astrocytic lactate levels as detected with Laconic during 
local stimulation of the somatosensory cortex (from Sotelo-Hitschfeld et al., 2015). The top 
image shows the expression of Laconic and Pyronic in neurons and astrocytes of the 
somatosensory cortex using viral vectors (adapted from Machler et al., 2016). Bottom 
images were taken from a transgenic mouse expressing ATeam in neurons described in 
Trevisiol et al., 2017.
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Table 1
Technique Strenghts Limitations
The Stage: location Immunohistochemistry Tissue context Reduced antibody availability
Accessible Epitope-masking
Low cost Mostly qualitative
Immunoblotting Semiquantitative Reduced antibody availability
Accessible Lacks cellular resolution
Protein-Protein interaction 
assays (Immunoprecipitation, 
Two-Hybrid, FRET, etc)
Specificity High rate of false negatives
Spatial resolution High rate of false positives
May miss indirect interactions in 
supramolecular complexes
The players: 
functional 
properties
Enzyme activity Precise functional characterization Non-physiological physicochemical context
Transporter activity Optimum manipulation of 
experimental parameters
Possible loss of cofactors and relevant 
interactions
Electrophysiology
Optogenetic actuators Cell type-specific manipulation Non-physiological ion perturbations
The play: 
concentrations and 
fluxes
Respirometry High temporal resolution Unavailable for adherent cells
  Clarke-type electrode Requires cell populations
Respirometry High throughput Low temporal resolution
  Multi-well plate Requires cell populations
No HCO3− present
Microdialysis In vivo Low spatial and temporal resolution
Available for many metabolites Local tissue disruption
Enzyme-based probes In vivo Low spatial resolution
Local tissue disruption
Available for few metabolites
Fluorescent glucose analogs Single cell resolution Variable kinetic properties
In vitro and in vivo
Non-invasive
Genetically-encoded sensors High specificity Calibration can be difficult
Single cell resolution Requires high expression levels
In vitro and in vivo Restricted to a small set of metabolites
Non-invasive
Mitochondrial autofluorescence High temporal resolution Small signal to noise
Low spatial resolution
Non-trivial interpretation
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Technique Strenghts Limitations
Isotope-labelled glucose Quantitative estimation of regional 
flux
Low temporal resolution
Lacks cellular resolution
Human studies
Magnetic Resonance Multiple metabolites Only abundant metabolites (<1mM)
Spectroscopy Non-invasive
Human studies Low temporal resolution
Hyperglycemia (13C-glucose)
Metabolomics Multiple metabolites Sample destruction
Low throughput
Intensive data analysis
High cost
Mathematical modeling Tackles complexity Key parameters are often unavailable
Low cost
Hidden assumptions
BOLD-fMRI Human studies Unclear relationship with energy 
metabolism
Glia. Author manuscript; available in PMC 2019 June 01.
